Detalhe da pesquisa
1.
S1Leitlinie Talgdrüsenkarzinom: S1Guideline Sebaceous Carcinoma.
J Dtsch Dermatol Ges
; 22(5): 730-749, 2024 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-38730519
2.
S1-Guideline Sebaceous Carcinoma.
J Dtsch Dermatol Ges
; 22(5): 730-747, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679790
3.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099927
4.
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
Blood
; 137(17): 2403-2416, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529322
5.
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
J Eur Acad Dermatol Venereol
; 37(5): 884-893, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433671
6.
S1-guideline cutaneous and subcutaneous leiomyosarcoma.
J Dtsch Dermatol Ges
; 21(5): 555-563, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999582
7.
Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
J Dtsch Dermatol Ges
; 21(5): 482-491, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035902
8.
Epidermal necrolysis in the context of immuno-oncologic medication as well as kinase inhibitors and biologics.
J Dtsch Dermatol Ges
; 20(6): 777-786, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711043
9.
S1-Guideline: Microscopically controlled surgery.
J Dtsch Dermatol Ges
; 20(12): 1663-1674, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448272
10.
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
J Dtsch Dermatol Ges
; 20(2): 235-243, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35099104
11.
S1 Guidelines for the Kaposi Sarcoma.
J Dtsch Dermatol Ges
; 20(6): 892-904, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657085
12.
S1-Leitlinie: Kaposi-Sarkom.
J Dtsch Dermatol Ges
; 20(6): 892-905, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711056
13.
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc).
Ann Rheum Dis
; 80(8): 1048-1056, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903093
14.
Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
Exp Dermatol
; 30(12): 1814-1819, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223669
15.
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy.
Int J Mol Sci
; 22(15)2021 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360781
16.
Therapy understanding and health related quality of life in stage III/IV melanoma patients treated with novel adjuvant therapies.
J Dtsch Dermatol Ges
; 19(2): 215-221, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491923
17.
Lupus erythematosus: correlation of clinical and histological findings and proposal for a modified disease classification.
J Dtsch Dermatol Ges
; 19(11): 1591-1599, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761515
18.
[Cutaneous manifestations of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation]. / Hautmanifestationen der akuten und chronischen Graft-versus-host-Erkrankung nach allogener Stammzelltransplantation.
Hautarzt
; 71(7): 557-568, 2020 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-32424469
19.
Rechallenge with checkpoint inhibitors in metastatic melanoma.
J Dtsch Dermatol Ges
; 18(5): 429-436, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32311829
20.
[Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma]. / Seltene Form einer segmentalen Neurofibromatose mit monströsem plexiformem Neurofibrom.
Hautarzt
; 70(8): 638-640, 2019 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-31076816